Kerusso Capital Management LLC Purchases New Position in The Clorox Company (NYSE:CLX)

Kerusso Capital Management LLC purchased a new stake in The Clorox Company (NYSE:CLXFree Report) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 17,863 shares of the company’s stock, valued at approximately $2,438,000.

Several other hedge funds have also bought and sold shares of CLX. Natixis Advisors L.P. grew its position in shares of Clorox by 24.3% during the 4th quarter. Natixis Advisors L.P. now owns 41,979 shares of the company’s stock valued at $5,985,000 after acquiring an additional 8,197 shares during the period. Apollon Wealth Management LLC grew its holdings in Clorox by 8.9% in the fourth quarter. Apollon Wealth Management LLC now owns 2,368 shares of the company’s stock valued at $338,000 after purchasing an additional 194 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Clorox by 2.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 678,825 shares of the company’s stock valued at $96,794,000 after buying an additional 15,187 shares in the last quarter. Wealthspire Advisors LLC acquired a new position in shares of Clorox during the 4th quarter worth approximately $212,000. Finally, Montag A & Associates Inc. lifted its position in shares of Clorox by 59.1% during the 4th quarter. Montag A & Associates Inc. now owns 2,376 shares of the company’s stock valued at $339,000 after buying an additional 883 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $164.75 on Friday. The company has a market capitalization of $20.46 billion, a P/E ratio of 85.36, a P/E/G ratio of 3.21 and a beta of 0.40. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $166.49. The stock’s fifty day moving average is $142.93 and its two-hundred day moving average is $142.85.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Equities analysts expect that The Clorox Company will post 6.56 EPS for the current year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 2.96%. The ex-dividend date of this dividend was Tuesday, August 13th. This is an increase from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio (DPR) is 252.85%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. DA Davidson restated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a research report on Friday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th. BNP Paribas began coverage on Clorox in a research report on Monday, June 24th. They issued an “underperform” rating and a $130.00 target price on the stock. Finally, TD Cowen assumed coverage on Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. Six research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to MarketBeat.com, Clorox has an average rating of “Hold” and an average price target of $143.50.

View Our Latest Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.